CBP Stock Overview
Provides revenue cycle consultative services and solutions in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Certive Solutions Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.01 |
| 52 Week High | CA$0.035 |
| 52 Week Low | CA$0.01 |
| Beta | 0.47 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -60.00% |
| 33 Year Change | -83.33% |
| 5 Year Change | -83.33% |
| Change since IPO | -92.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| CBP | CA Healthcare Services | CA Market | |
|---|---|---|---|
| 7D | 0% | 5.6% | -1.5% |
| 1Y | -60.0% | 108.7% | 21.1% |
Return vs Industry: CBP underperformed the Canadian Healthcare Services industry which returned 108.7% over the past year.
Return vs Market: CBP underperformed the Canadian Market which returned 21.1% over the past year.
Price Volatility
| CBP volatility | |
|---|---|
| CBP Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 9.8% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.5% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: CBP's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine CBP's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Tom Marreel | certivehealth.com |
Certive Solutions Inc. provides revenue cycle consultative services and solutions in the United States. It offers healthcare revenue cycle management services and management solutions. It is also involved in the selling and servicing a cybersecurity suite of products to the healthcare industry.
Certive Solutions Inc. Fundamentals Summary
| CBP fundamental statistics | |
|---|---|
| Market cap | CA$1.78m |
| Earnings (TTM) | -CA$2.20m |
| Revenue (TTM) | CA$1.81m |
1.0x
P/S Ratio-0.8x
P/E RatioIs CBP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CBP income statement (TTM) | |
|---|---|
| Revenue | US$1.30m |
| Cost of Revenue | US$955.16k |
| Gross Profit | US$344.81k |
| Other Expenses | US$1.92m |
| Earnings | -US$1.58m |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0089 |
| Gross Margin | 26.52% |
| Net Profit Margin | -121.51% |
| Debt/Equity Ratio | -50.4% |
How did CBP perform over the long term?
See historical performance and comparison